Cerebrospinal fluid inflammatory biomarkers predicting interferon-beta response in MS patients

BACKGROUND AND AIMS: Interferon beta (IFNb) is a safe first-line drug commonly used for relapsing-remitting (RR)-MS. Nevertheless, a considerable proportion of patients do not respond to IFNb treatment. Therefore, until now, a number of studies have investigated various markers that could predict th...

Descripción completa

Detalles Bibliográficos
Autores principales: Stampanoni Bassi, Mario, Drulovic, Jelena, Pekmezovic, Tatjana, Iezzi, Ennio, Sica, Francesco, Gilio, Luana, Gentile, Antonietta, Musella, Alessandra, Mandolesi, Georgia, Furlan, Roberto, Finardi, Annamaria, Marfia, Girolama Alessandra, Bellantonio, Paolo, Fantozzi, Roberta, Centonze, Diego, Buttari, Fabio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7727083/
https://www.ncbi.nlm.nih.gov/pubmed/33343708
http://dx.doi.org/10.1177/1756286420970833

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7727083/
https://www.ncbi.nlm.nih.gov/pubmed/33343708
http://dx.doi.org/10.1177/1756286420970833

Ejemplares similares